We are live on
!
Find out more
SCCM
Schafer Cullen Capital Management Portfolio holdings
AUM
$491M
1-Year Est. Return
41.48%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+41.48%
3 Year Est. Return
+28.44%
5 Year Est. Return
+53.22%
10 Year Est. Return
–
AUM
$8.04B
AUM Growth
+$252M
(+3.2%)
Cap. Flow
+$6.62M
Cap. Flow
% of AUM
0.08%
Top 10 Holdings %
Top 10 Hldgs %
22.29%
Holding
290
New
11
Increased
104
Reduced
121
Closed
11
Top Buys
| 1 |
ExxonMobil
XOM
|
+$18.7M |
| 2 |
Novartis
NVS
|
+$18.5M |
| 3 |
Johnson Controls International
JCI
|
+$15.7M |
| 4 |
Archer Daniels Midland
ADM
|
+$15.1M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$10.9M |
Top Sells
| 1 |
Philip Morris
PM
|
+$38.8M |
| 2 |
UN
Unilever NV New York Registry Shares
UN
|
+$28.6M |
| 3 |
CEO
CNOOC Limited
CEO
|
+$27.2M |
| 4 |
3M
MMM
|
+$24.2M |
| 5 |
GSK
GSK
|
+$13.2M |
Sector Composition
| 1 | Financials | 15.65% |
| 2 | Healthcare | 12.88% |
| 3 | Industrials | 9.39% |
| 4 | Technology | 8.75% |
| 5 | Energy | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Novartis
NVS
$288B
| $232M | 2.89% |
3,103,156
+260,354
| +9% | +$18.5M |
|
|
UN
2
DELISTED
Unilever NV New York Registry Shares
UN
| $218M | 2.72% |
3,949,452
-529,421
| -12% | -$28.6M |
|
3
HSBC
HSBC
$345B
| $184M | 2.29% |
4,339,579
+40,967
| +1% | +$1.59M |
|
|
RDS.B
4
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $176M | 2.19% |
3,229,630
+196,151
| +6% | +$10.9M |
|
5
JPMorgan Chase
JPM
$930B
| $171M | 2.13% |
1,872,480
-85,369
| -4% | -$7.37M |
|
6
BCE
BCE
$20.1B
| $169M | 2.11% |
3,760,055
+209,395
| +6% | +$9.44M |
|
7
Johnson & Johnson
JNJ
$595B
| $168M | 2.1% |
1,273,652
-20,101
| -2% | -$2.56M |
|
8
Chubb
CB
$131B
| $161M | 2.01% |
1,110,238
-29,649
| -3% | -$4.17M |
|
9
Welltower
WELL
$165B
| $157M | 1.95% |
2,095,543
-35,330
| -2% | -$2.58M |
|
10
Cisco
CSCO
$441B
| $154M | 1.91% |
4,913,113
+59,135
| +1% | +$1.93M |
|
11
Microsoft
MSFT
$2.94T
| $152M | 1.89% |
2,199,334
-92,175
| -4% | -$6.33M |
|
12
Altria Group
MO
$118B
| $151M | 1.88% |
2,030,191
-136,012
| -6% | -$9.95M |
|
13
Diageo
DEO
$45.7B
| $148M | 1.84% |
1,235,808
-20,459
| -2% | -$2.44M |
|
14
AstraZeneca
AZN
$261B
| $144M | 1.79% |
2,106,132
+5,001
| +0.2% | +$327K |
|
15
Boeing
BA
$172B
| $144M | 1.79% |
725,815
-41,315
| -5% | -$7.69M |
|
16
Chevron
CVX
$362B
| $143M | 1.78% |
1,367,999
+83,246
| +6% | +$8.82M |
|
|
DD
17
DELISTED
Du Pont De Nemours E I
DD
| $141M | 1.75% |
1,741,586
-31,260
| -2% | -$2.5M |
|
18
Merck
MRK
$305B
| $140M | 1.74% |
2,286,366
-63,926
| -3% | -$3.89M |
|
19
AT&T
T
$149B
| $139M | 1.73% |
4,890,314
+65,984
| +1% | +$1.95M |
|
20
Wells Fargo
WFC
$265B
| $137M | 1.71% |
2,480,541
+57,401
| +2% | +$3.08M |
|
21
NextEra Energy
NEE
$186B
| $131M | 1.63% |
3,736,084
-211,316
| -5% | -$7.22M |
|
22
Travelers Companies
TRV
$70B
| $130M | 1.62% |
1,028,604
-13,048
| -1% | -$1.61M |
|
23
GE Aerospace
GE
$376B
| $130M | 1.61% |
1,001,850
+26,619
| +3% | +$3.65M |
|
24
MetLife
MET
$59.3B
| $122M | 1.51% |
2,482,314
+148,160
| +6% | +$6.87M |
|
25
Pfizer
PFE
$141B
| $116M | 1.44% |
3,641,808
-68,566
| -2% | -$2.16M |
|
Similar funds
CNC
SRAM
PA
FBP
SGMP
RG
LFA
RHFI